Amendment No. 5 to Product Supply AgreementProduct Supply Agreement • November 5th, 2010 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
This Amendment No. 5 (“Amendment”), effective as of August 31, 2010 (the “Effective Date”), is entered into by and between Talecris Biotherapeutics, Inc. (“Talecris”), with a business address of 79 T.W. Alexander Drive, 4101 Research Commons, P.O. Box 110526, Research Triangle Park, North Carolina 27709, and Emergent Product Development Gaithersburg Inc. (“Emergent”), with a business address of 300 Professional Drive, Gaithersburg, Maryland 20879. For the purposes of this Amendment, Emergent and Talecris shall each be deemed a “Party” and together the “Parties”.
